Experience

Davis Polk advised the respective agents of the Brazilian underwriters in connection with the follow-on offering by Petróleo Brasileiro S.A. — Petrobras of 393,187,500 common shares of BR…

Davis Polk is acting as special tax counsel to Pfizer Inc. on the combination of its off-patent branded and generic established medicines business, Upjohn, with Mylan N.V. Under the terms…

Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A and Regulation S offering by Terrafina of $500 million aggregate principal amount…

Davis Polk advised Uniti Group Inc. (“Uniti Group”) and Uniti Fiber Holdings Inc. (“Uniti Fiber,” and together with Uniti Group, “Uniti”) in connection with a Rule 144A offering of $345…

Davis Polk advised the representatives of the underwriters in connection with the $163.3 million initial public offering of 9,074,776 shares of common stock of Stoke Therapeutics, Inc.,…

Davis Polk advised an ad hoc group of holders of the unsecured notes and the first-lien notes of Jones Energy, Inc. in connection with Jones Energy’s comprehensive balance sheet…

Davis Polk advised the joint book-running managers in connection with the secondary offering of 15,000,000 shares of common stock of SolarWinds Corporation by certain of SolarWinds’…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Emerson Electric Co. of €500 million aggregate principal amount of 0.375% notes…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $64.8 million follow-on offering of common stock of Magenta Therapeutics,…

Davis Polk is advising Uniti Group Inc. in connection with the sale of its tower business in Mexico, Colombia and Nicaragua to Phoenix Tower International Spain ETVE, S.L.U., a portfolio…